semaglutide plus tirzepatide Maintenance therapy on or Switching from Semaglutide to Tirzepatide:
Description
In this issue of Diabetologia, Kang et al (DOI: 10.1007/s00125-012-2776-x ) provide evidence that in addition to glucotoxicity, lipotoxicity also affects incretin receptor expression and signalling in insulin-secreting cells and isolated islets
Descubre el estado actual de esta tecnologa transdrmica, por qu no hay productos aprobados por la FDA, y qu alternativas teraputicas validadas existen para el tratamiento de diabetes tipo 2 y control de peso.
Wegovy, Saxenda and Mounjaro can cause fatigue
Learn when it could become available.
Results GLP-1RA monotherapy elicited only modest improvements in glycemia and hepatic lipid accumulation, with effects waning over time
